abstract |
The present invention relates to synthetic chemical compositions useful for modulating Toll-like receptor (TLR) mediated immune responses. In particular, the present invention relates to agonists of Toll-like receptor 9 (TLR9) that cause unique cytokine and chemokine profiles. |